Sulfated chitosan as tear substitute with no antimicrobial activity

Carbohydr Polym. 2013 Jan 2;91(1):92-9. doi: 10.1016/j.carbpol.2012.08.011. Epub 2012 Aug 10.

Abstract

Chitosan of high molar mass and with 82% deacetylation was sulfated using two procedures and characterized. In the first method sample chitosan-S1 was produced using chlorosulfonic acid as the sulfating agent and N,N-dimethylformamide as the medium, and in the second method (chitosan-S2) formic acid was also used. The degrees of sulfation were 0.87 (chitosan-S1) and 0.67 (chitosan-S2). FTIR spectra showed bands at 1230, 800 and 580 cm(-1), attributed to sulfation. Moisture content followed the order: chitosan-S-0.87>chitosan-S-0.67>chitosan. Chain depolymerization was verified by GPC. Aqueous solutions showed pseudoplastic behavior and the viscosity at a concentration of 0.3% (w/v) was higher than that of healthy human tears (close to 3 mPas at shear rate 130 s(-1)). Substitutions in the C2NH and in C6OH groups were verified by NMR. Antimicrobial activity against Staphylococcus aureus and Pseudomonas aeruginosa was not observed. Considering that chitosan-S-0.67 had a higher solubility, less chain depolymerization, higher yield and better thermal stability in comparison with chitosan-S-0.87, the derivative with DS 0.67 offered the greatest potential for use in formulations of tear substitutes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / pharmacology*
  • Chitosan / chemistry*
  • Chitosan / pharmacology*
  • Humans
  • Ophthalmic Solutions / chemistry*
  • Ophthalmic Solutions / pharmacology*
  • Osmolar Concentration
  • Pseudomonas aeruginosa / drug effects
  • Rheology
  • Staphylococcus aureus / drug effects
  • Sulfates / chemistry*

Substances

  • Anti-Bacterial Agents
  • Ophthalmic Solutions
  • Sulfates
  • Chitosan